Ellevest Inc’s Fennec Pharmaceuticals FENC Stock Holding History

Ellevest Inc’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-66	Closed	–	–	1310
2021 Q1	$0	Hold	66	–	–	﹤0.01%	1283
2020 Q4	$0	Buy	+66	New	+$503	﹤0.01%	1240

Other funds holding FENC

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Russell Investments Group

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Ellevest Inc's FENC Position: Q2 2021 in Review

Ellevest Inc sold out of Fennec Pharmaceuticals (FENC) in Q2 2021, closing a stake of 66 shares.

Ellevest Inc first reported a position in FENC in Q4 2020 and held it in 2 quarters. The position peaked at $0 in Q1 2021. 39 funds tracked by Wall St. Rank hold FENC as of Q2 2021.

Ellevest Inc reported no remaining Fennec Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Ellevest Inc sold 66 Fennec Pharmaceuticals shares in Q2 2021.
Ellevest Inc first reported a position in Fennec Pharmaceuticals in Q4 2020 and held it in 2 quarters.
Ellevest Inc's Fennec Pharmaceuticals position peaked at $0 in Q1 2021.
39 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2021.

Based on Ellevest Inc's 13F filing for Q2 2021, filed 13 Jul 2021.